Work

Phase II trial evaluating HER2 targeted activated T cells in advanced HER2 low expressing breast cancer patients.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.3073

Authors: Deepa Bai Jagtap, Archana Thakur, Abhinav Deol, Zaid Al-Kadhimi, Michael S. Simon, Lawrence E. Flaherty, Anthony Frank Shields, Dana Schalk, Elyse Paul, Vidya Kondadasula, Qin Liu, Lawrence G. Lum

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, Winship Cancer Institute, The Wistar Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599040232

Cites:

Cited by: 1

Related to: 10